PatrickJ.HughesMD

PubMed

• A combined inhibitor of matrix metalloproteinase activity and tumour necrosis factor-alpha processing attenuates experimental autoimmune neuritis.
  Redford EJ, Smith KJ, Gregson NA, Davies M, Hughes P, Gearing AJ, Miller K, Hughes RA> ;Brain. 1997-10-01
• Activation of NMDA and muscarinic receptors induces nur-77 mRNA in hippocampal neurons.
  Dragunow M, Abraham W, Hughes P> ;Brain Res. Mol. Brain Res.. 1996-03-01
• MK-801 does not attenuate immediate-early gene expression following an amygdala afterdischarge.
  Hughes P, Singleton K, Dragunow M> ;Exp. Neurol.. 1994-08-01
• Small-fiber dysfunction in a Borrelia burgdorferi infection.
  Hughes PJ, Lane RJ, Cutler SJ, Wright DJ, Abraham RM, Wade JP, Levy DM> ;Muscle Nerve. 1993-02-01
• Wildervanck or cervico-oculo-acoustic syndrome and MRI findings.
  Hughes PJ, Davies PT, Roche SW, Matthews TD, Lane RJ> ;J. Neurol. Neurosurg. Psychiatr.. 1991-06-01
• Dual labelling of circulating CD8 cells in patients with multiple sclerosis.
  Hughes PJ, Kirk PF, Compston DA> ;J. Neurol. Neurosurg. Psychiatr.. 1989-01-01
• Peripheral blood lymphocyte phenotype and function in multiple sclerosis.
  Hughes PJ, Compston DA> ;J. Neurol. Neurosurg. Psychiatr.. 1988-09-01
• Factors influencing circulating OKT8 cell phenotypes in patients with multiple sclerosis.
  Hughes PJ, Kirk PF, Dyas J, Munro JA, Welsh KI, Compston DA> ;J. Neurol. Neurosurg. Psychiatr.. 1987-09-01
• Human T-cell lymphotrophic viruses in patients with multiple sclerosis.
  Swingler RJ, Hughes PJ, Munro JA, Compston DA> ;J. Neurol.. 1987-08-01
• Triazine-dye affinity; chromatography.
  Atkinson T, Hammond PM, Hartwell RD, Hughes P, Scawen MD, Sherwood RF, Small DA, Bruton CJ, Harvey MJ, Lowe CR> ;Biochem. Soc. Trans.. 1981-08-01
• Join now to see all